Data Published in Prenatal Diagnosis Demonstrate Natera’s Non-Invasive Prenatal Testing Technology Enables Accurate Detection of Chromosomal Abnormalities Using Maternal Blood

Published: Oct 31, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natera today announced that data from a clinical study published in Prenatal Diagnosis demonstrate the ability of the company’s non-invasive prenatal screening test to detect chromosomal abnormalities from fetal cell-free DNA found in maternal blood with high accuracy.

Back to news